CVS Health Corp (CVS)vsElevance Health Inc (ELV)
CVS
CVS Health Corp
$71.48
-0.53%
HEALTHCARE · Cap: $90.94B
ELV
Elevance Health Inc
$291.48
+0.11%
HEALTHCARE · Cap: $64.33B
Smart Verdict
WallStSmart Research — data-driven comparison
CVS Health Corp generates 101% more annual revenue ($399.83B vs $199.13B). CVS leads profitability with a 44.0% profit margin vs 2.8%. CVS appears more attractively valued with a PEG of 0.21. ELV earns a higher WallStSmart Score of 67/100 (B-).
CVS
Buy65
out of 100
Grade: C+
ELV
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-18.4%
Fair Value
$65.05
Current Price
$71.48
$6.43 premium
Margin of Safety
+75.3%
Fair Value
$1179.83
Current Price
$291.48
$888.35 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Reasonable price relative to book value
Keeps 44 of every $100 in revenue as profit
Earnings expanding 76.6% YoY
Large-cap with strong market position
Generating 2.6B in free cash flow
Attractively priced relative to earnings
Reasonable price relative to book value
Large-cap with strong market position
Earnings expanding 36.3% YoY
Areas to Watch
ROE of 2.3% — below average capital efficiency
Operating margin of 1.6%
Elevated debt levels
Premium valuation, high expectations priced in
2.8% margin — thin
Operating margin of 1.5%
Weak financial health signals
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : CVS
The strongest argument for CVS centers on PEG Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 44.0% and operating margin at 1.6%. PEG of 0.21 suggests the stock is reasonably priced for its growth.
Bull Case : ELV
The strongest argument for ELV centers on P/E Ratio, Price/Book, Market Cap. PEG of 1.17 suggests the stock is reasonably priced for its growth.
Bear Case : CVS
The primary concerns for CVS are Return on Equity, Operating Margin, Debt/Equity. A P/E of 51.4x leaves little room for execution misses.
Bear Case : ELV
The primary concerns for ELV are Profit Margin, Operating Margin, Piotroski F-Score. Thin 2.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
CVS profiles as a mature stock while ELV is a value play — different risk/reward profiles.
ELV carries more volatility with a beta of 0.47 — expect wider price swings.
ELV is growing revenue faster at 9.5% — sustainability is the question.
CVS generates stronger free cash flow (2.6B), providing more financial flexibility.
Bottom Line
ELV scores higher overall (67/100 vs 65/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CVS Health Corp
HEALTHCARE · HEALTHCARE PLANS · USA
CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
Visit Website →Elevance Health Inc
HEALTHCARE · HEALTHCARE PLANS · USA
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?